Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01215942




Registration number
NCT01215942
Ethics application status
Date submitted
5/10/2010
Date registered
7/10/2010
Date last updated
11/06/2018

Titles & IDs
Public title
An Open Label Study for Participants With Rheumatoid Arthritis
Scientific title
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Secondary ID [1] 0 0
H9B-MC-BCDP
Secondary ID [2] 0 0
13419
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Rheumatoid Arthritis 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Osteoarthritis
Inflammatory and Immune System 0 0 0 0
Rheumatoid arthritis

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - LY2127399

Experimental: 120 milligrams (mg) of LY2127399 - Given every 4 weeks for 240 weeks for those participants from Study BCDO or Study BCDV. Participants who had been receiving placebo immediately prior to enrollment will receive a 240 mg loading dose when initiating treatment.

Or

Given every 4 weeks for 168 weeks for those participants from Study BCDM.

Experimental: 90 mg LY2127399 - Given every 2 weeks for 240 weeks for those participants from Study BCDO or Study BCDV. Participants who had been receiving placebo immediately prior to enrollment will receive a 180 mg loading dose when initiating treatment.

Or

Given every 2 weeks for 168 weeks for those participants from Study BCDM.


Treatment: Drugs: LY2127399
Administered Subcutaneously
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Number of Participants Who Had Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Adverse Event of Special Interest (AESI)During Treatment Period
Timepoint [1] 0 0
up to 84.4 weeks during treatment period
Primary outcome [2] 0 0
Percentage of Participants Developing Anti-LY2127399 Antibodies
Timepoint [2] 0 0
Baseline through Weeks 4, 24, 48 and 72
Primary outcome [3] 0 0
Change From Baseline in Absolute B Cell Counts
Timepoint [3] 0 0
Baseline, Week 48
Primary outcome [4] 0 0
Change From Baseline in Serum Immunoglobulin (Ig) Levels
Timepoint [4] 0 0
Baseline, Week 48
Secondary outcome [1] 0 0
Percentage of Participants With American College of Rheumatology 20% Response (ACR20)
Timepoint [1] 0 0
Baseline through Weeks 12, 24 and 48
Secondary outcome [2] 0 0
Change From Baseline in Disease Activity Score Based on 28 Joint Count and C-Reactive Protein Level (DAS28-CRP)
Timepoint [2] 0 0
Baseline, 240 weeks
Secondary outcome [3] 0 0
Percentage of Participants With DAS28-Based European League Against Rheumatism (EULAR-28) Response
Timepoint [3] 0 0
Baseline through 240 weeks
Secondary outcome [4] 0 0
Change From Baseline in Medical Outcomes Study 36-Item Short Form (SF-36) Health Survey Domain Scores and Summary Scores
Timepoint [4] 0 0
Baseline, 240 weeks
Secondary outcome [5] 0 0
Change From Baseline in Tender Joint Count (68 Joint Count)
Timepoint [5] 0 0
Baseline, 240 weeks
Secondary outcome [6] 0 0
Change From Baseline in Swollen Joint Count (66 Joint Count)
Timepoint [6] 0 0
Baseline, 240 weeks
Secondary outcome [7] 0 0
Change From Baseline in Participant's Assessment of Pain [Visual Analog Scale (VAS)]
Timepoint [7] 0 0
Baseline, 240 weeks
Secondary outcome [8] 0 0
Change From Baseline in Participants Global Assessment of Disease Activity (VAS)
Timepoint [8] 0 0
Baseline, 240 weeks
Secondary outcome [9] 0 0
Change From Baseline in Physicians Global Assessment of Disease Activity (VAS)
Timepoint [9] 0 0
Baseline, 240 weeks
Secondary outcome [10] 0 0
Change From Baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI)
Timepoint [10] 0 0
Baseline, 240 weeks
Secondary outcome [11] 0 0
Change From Baseline in CRP
Timepoint [11] 0 0
Baseline, 240 weeks
Secondary outcome [12] 0 0
American College of Rheumatology Percent Improvement (ACR-N)
Timepoint [12] 0 0
Baseline through 240 weeks

Eligibility
Key inclusion criteria
* Have completed 24 weeks of participation in Study H9B-MC-BCDO or Study H9B-MC-BCDV, or have completed 100 weeks of participation in Study H9B-MC-BCDM
* Woman must not be pregnant, breastfeeding, or become pregnant during the study
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Current presence of a serious disorder or illness

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/06/2011
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/02/2014
Sample size
Target
Accrual to date
Final
1086
Recruitment in Australia
Recruitment state(s)
NSW,QLD
Recruitment hospital [1] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Campbelltown
Recruitment hospital [2] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Kogarah
Recruitment hospital [3] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Herston
Recruitment hospital [4] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Malvern East
Recruitment postcode(s) [1] 0 0
2560 - Campbelltown
Recruitment postcode(s) [2] 0 0
04266-010 - Kogarah
Recruitment postcode(s) [3] 0 0
4029 - Herston
Recruitment postcode(s) [4] 0 0
3145 - Malvern East
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
Arkansas
Country [4] 0 0
United States of America
State/province [4] 0 0
California
Country [5] 0 0
United States of America
State/province [5] 0 0
Colorado
Country [6] 0 0
United States of America
State/province [6] 0 0
Delaware
Country [7] 0 0
United States of America
State/province [7] 0 0
Florida
Country [8] 0 0
United States of America
State/province [8] 0 0
Georgia
Country [9] 0 0
United States of America
State/province [9] 0 0
Idaho
Country [10] 0 0
United States of America
State/province [10] 0 0
Illinois
Country [11] 0 0
United States of America
State/province [11] 0 0
Indiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Kansas
Country [13] 0 0
United States of America
State/province [13] 0 0
Kentucky
Country [14] 0 0
United States of America
State/province [14] 0 0
Louisiana
Country [15] 0 0
United States of America
State/province [15] 0 0
Maryland
Country [16] 0 0
United States of America
State/province [16] 0 0
Massachusetts
Country [17] 0 0
United States of America
State/province [17] 0 0
Michigan
Country [18] 0 0
United States of America
State/province [18] 0 0
Mississippi
Country [19] 0 0
United States of America
State/province [19] 0 0
Missouri
Country [20] 0 0
United States of America
State/province [20] 0 0
Montana
Country [21] 0 0
United States of America
State/province [21] 0 0
Nebraska
Country [22] 0 0
United States of America
State/province [22] 0 0
Nevada
Country [23] 0 0
United States of America
State/province [23] 0 0
New Hampshire
Country [24] 0 0
United States of America
State/province [24] 0 0
New Jersey
Country [25] 0 0
United States of America
State/province [25] 0 0
New Mexico
Country [26] 0 0
United States of America
State/province [26] 0 0
New York
Country [27] 0 0
United States of America
State/province [27] 0 0
North Carolina
Country [28] 0 0
United States of America
State/province [28] 0 0
North Dakota
Country [29] 0 0
United States of America
State/province [29] 0 0
Ohio
Country [30] 0 0
United States of America
State/province [30] 0 0
Oklahoma
Country [31] 0 0
United States of America
State/province [31] 0 0
Oregon
Country [32] 0 0
United States of America
State/province [32] 0 0
Pennsylvania
Country [33] 0 0
United States of America
State/province [33] 0 0
South Carolina
Country [34] 0 0
United States of America
State/province [34] 0 0
Tennessee
Country [35] 0 0
United States of America
State/province [35] 0 0
Texas
Country [36] 0 0
United States of America
State/province [36] 0 0
Vermont
Country [37] 0 0
United States of America
State/province [37] 0 0
Virginia
Country [38] 0 0
United States of America
State/province [38] 0 0
Washington
Country [39] 0 0
United States of America
State/province [39] 0 0
West Virginia
Country [40] 0 0
United States of America
State/province [40] 0 0
Wisconsin
Country [41] 0 0
Argentina
State/province [41] 0 0
Buenos Aires
Country [42] 0 0
Argentina
State/province [42] 0 0
Córdoba
Country [43] 0 0
Argentina
State/province [43] 0 0
Lujan
Country [44] 0 0
Argentina
State/province [44] 0 0
Mar Del Plata
Country [45] 0 0
Argentina
State/province [45] 0 0
Quilmes
Country [46] 0 0
Argentina
State/province [46] 0 0
Rosario
Country [47] 0 0
Argentina
State/province [47] 0 0
San Juan
Country [48] 0 0
Argentina
State/province [48] 0 0
Tucuman
Country [49] 0 0
Brazil
State/province [49] 0 0
Campinas
Country [50] 0 0
Brazil
State/province [50] 0 0
Caxias Do Sul
Country [51] 0 0
Brazil
State/province [51] 0 0
Curitiba
Country [52] 0 0
Brazil
State/province [52] 0 0
Fortaleza
Country [53] 0 0
Brazil
State/province [53] 0 0
Juiz De Fora
Country [54] 0 0
Brazil
State/province [54] 0 0
Rio De Janeiro
Country [55] 0 0
Brazil
State/province [55] 0 0
Setor Oeste/Goiania
Country [56] 0 0
Brazil
State/province [56] 0 0
São Paulo
Country [57] 0 0
Bulgaria
State/province [57] 0 0
Burgas
Country [58] 0 0
Bulgaria
State/province [58] 0 0
Pleven
Country [59] 0 0
Bulgaria
State/province [59] 0 0
Plovdiv
Country [60] 0 0
Bulgaria
State/province [60] 0 0
Rousse
Country [61] 0 0
Bulgaria
State/province [61] 0 0
Sevlievo
Country [62] 0 0
Bulgaria
State/province [62] 0 0
Sofia
Country [63] 0 0
Bulgaria
State/province [63] 0 0
Varna
Country [64] 0 0
Colombia
State/province [64] 0 0
Bogota
Country [65] 0 0
Colombia
State/province [65] 0 0
Medellin
Country [66] 0 0
Croatia
State/province [66] 0 0
Opatija
Country [67] 0 0
Croatia
State/province [67] 0 0
Osijek
Country [68] 0 0
Croatia
State/province [68] 0 0
Rijeka
Country [69] 0 0
France
State/province [69] 0 0
Montpellier
Country [70] 0 0
France
State/province [70] 0 0
Nice
Country [71] 0 0
France
State/province [71] 0 0
Orleans
Country [72] 0 0
France
State/province [72] 0 0
Paris
Country [73] 0 0
France
State/province [73] 0 0
Saint-Etienne Cedex 02
Country [74] 0 0
France
State/province [74] 0 0
Strasbourg
Country [75] 0 0
France
State/province [75] 0 0
Toulouse
Country [76] 0 0
Germany
State/province [76] 0 0
Bad Doberan
Country [77] 0 0
Germany
State/province [77] 0 0
Bad Nauheim
Country [78] 0 0
Germany
State/province [78] 0 0
Baden-Baden
Country [79] 0 0
Germany
State/province [79] 0 0
Berlin
Country [80] 0 0
Germany
State/province [80] 0 0
Dresden
Country [81] 0 0
Germany
State/province [81] 0 0
Erlangen
Country [82] 0 0
Germany
State/province [82] 0 0
Frankfurt
Country [83] 0 0
Germany
State/province [83] 0 0
Göttingen
Country [84] 0 0
Germany
State/province [84] 0 0
Koeln
Country [85] 0 0
Germany
State/province [85] 0 0
Munich
Country [86] 0 0
Greece
State/province [86] 0 0
Haidari/Athens
Country [87] 0 0
Greece
State/province [87] 0 0
Heraklion
Country [88] 0 0
Greece
State/province [88] 0 0
Larissa
Country [89] 0 0
Greece
State/province [89] 0 0
Thessaloniki
Country [90] 0 0
Hungary
State/province [90] 0 0
Baja
Country [91] 0 0
Hungary
State/province [91] 0 0
Balassagyarmat
Country [92] 0 0
Hungary
State/province [92] 0 0
Budapest
Country [93] 0 0
Hungary
State/province [93] 0 0
Debrecen
Country [94] 0 0
Hungary
State/province [94] 0 0
Esztergom
Country [95] 0 0
Hungary
State/province [95] 0 0
Kiskunhalas
Country [96] 0 0
Hungary
State/province [96] 0 0
Nyiregyhaza
Country [97] 0 0
Hungary
State/province [97] 0 0
Satoraljaujhely
Country [98] 0 0
Hungary
State/province [98] 0 0
Szikszo
Country [99] 0 0
Hungary
State/province [99] 0 0
Veszprem
Country [100] 0 0
India
State/province [100] 0 0
Ahmedabad
Country [101] 0 0
India
State/province [101] 0 0
Bangalore
Country [102] 0 0
India
State/province [102] 0 0
Chennai
Country [103] 0 0
India
State/province [103] 0 0
Hyderabaad
Country [104] 0 0
India
State/province [104] 0 0
Jaipur
Country [105] 0 0
India
State/province [105] 0 0
Lucknow
Country [106] 0 0
India
State/province [106] 0 0
Mysore
Country [107] 0 0
India
State/province [107] 0 0
Nellore
Country [108] 0 0
India
State/province [108] 0 0
New Delhi
Country [109] 0 0
India
State/province [109] 0 0
Secunderabad
Country [110] 0 0
India
State/province [110] 0 0
Surat
Country [111] 0 0
Japan
State/province [111] 0 0
Aichi
Country [112] 0 0
Japan
State/province [112] 0 0
Chiba
Country [113] 0 0
Japan
State/province [113] 0 0
Fukuoka
Country [114] 0 0
Japan
State/province [114] 0 0
Gunma
Country [115] 0 0
Japan
State/province [115] 0 0
Hokkaido
Country [116] 0 0
Japan
State/province [116] 0 0
Hyogo
Country [117] 0 0
Japan
State/province [117] 0 0
Ibaragi
Country [118] 0 0
Japan
State/province [118] 0 0
Ibaraki
Country [119] 0 0
Japan
State/province [119] 0 0
Japan
Country [120] 0 0
Japan
State/province [120] 0 0
Kagoshima
Country [121] 0 0
Japan
State/province [121] 0 0
Kanagawa
Country [122] 0 0
Japan
State/province [122] 0 0
Kumamoto
Country [123] 0 0
Japan
State/province [123] 0 0
Mie
Country [124] 0 0
Japan
State/province [124] 0 0
Miyagi
Country [125] 0 0
Japan
State/province [125] 0 0
Miyazaki
Country [126] 0 0
Japan
State/province [126] 0 0
Nagano
Country [127] 0 0
Japan
State/province [127] 0 0
Nagasaki
Country [128] 0 0
Japan
State/province [128] 0 0
Nara
Country [129] 0 0
Japan
State/province [129] 0 0
Ohita
Country [130] 0 0
Japan
State/province [130] 0 0
Okayama
Country [131] 0 0
Japan
State/province [131] 0 0
Osaka
Country [132] 0 0
Japan
State/province [132] 0 0
Saga
Country [133] 0 0
Japan
State/province [133] 0 0
Saitama
Country [134] 0 0
Japan
State/province [134] 0 0
Sapporo-Shi
Country [135] 0 0
Japan
State/province [135] 0 0
Shizuoka
Country [136] 0 0
Japan
State/province [136] 0 0
Tokushima
Country [137] 0 0
Japan
State/province [137] 0 0
Tokyo
Country [138] 0 0
Japan
State/province [138] 0 0
Toyama
Country [139] 0 0
Korea, Republic of
State/province [139] 0 0
Busan
Country [140] 0 0
Korea, Republic of
State/province [140] 0 0
Daegu
Country [141] 0 0
Korea, Republic of
State/province [141] 0 0
Daejeon
Country [142] 0 0
Korea, Republic of
State/province [142] 0 0
Incheon
Country [143] 0 0
Korea, Republic of
State/province [143] 0 0
Seongnam-Si
Country [144] 0 0
Korea, Republic of
State/province [144] 0 0
Seoul
Country [145] 0 0
Korea, Republic of
State/province [145] 0 0
Suwon-City
Country [146] 0 0
Lithuania
State/province [146] 0 0
Alytus
Country [147] 0 0
Lithuania
State/province [147] 0 0
Kaunas
Country [148] 0 0
Lithuania
State/province [148] 0 0
Klaipedos
Country [149] 0 0
Lithuania
State/province [149] 0 0
Siauliai
Country [150] 0 0
Lithuania
State/province [150] 0 0
Vilnius
Country [151] 0 0
Malaysia
State/province [151] 0 0
Batu Caves
Country [152] 0 0
Malaysia
State/province [152] 0 0
Kota Bahru
Country [153] 0 0
Malaysia
State/province [153] 0 0
Kuantan Pahang
Country [154] 0 0
Malaysia
State/province [154] 0 0
Perak
Country [155] 0 0
Malaysia
State/province [155] 0 0
Putrajaya
Country [156] 0 0
Malaysia
State/province [156] 0 0
Sarawak
Country [157] 0 0
Mexico
State/province [157] 0 0
Aguascalientes
Country [158] 0 0
Mexico
State/province [158] 0 0
Barrio San Mateo
Country [159] 0 0
Mexico
State/province [159] 0 0
Chihuahua
Country [160] 0 0
Mexico
State/province [160] 0 0
Guadalajara
Country [161] 0 0
Mexico
State/province [161] 0 0
Mexicali
Country [162] 0 0
Mexico
State/province [162] 0 0
Mexico City
Country [163] 0 0
Mexico
State/province [163] 0 0
Monterrey
Country [164] 0 0
Mexico
State/province [164] 0 0
Morelia
Country [165] 0 0
Mexico
State/province [165] 0 0
Queretaro
Country [166] 0 0
Mexico
State/province [166] 0 0
San Luis Potosi
Country [167] 0 0
Mexico
State/province [167] 0 0
Tijuana
Country [168] 0 0
New Zealand
State/province [168] 0 0
Hamilton
Country [169] 0 0
New Zealand
State/province [169] 0 0
Rotorua
Country [170] 0 0
New Zealand
State/province [170] 0 0
Tauranga
Country [171] 0 0
New Zealand
State/province [171] 0 0
Timaru
Country [172] 0 0
Poland
State/province [172] 0 0
Bydgoszcz
Country [173] 0 0
Poland
State/province [173] 0 0
Dzialdowo
Country [174] 0 0
Poland
State/province [174] 0 0
Elblag
Country [175] 0 0
Poland
State/province [175] 0 0
Gdynia
Country [176] 0 0
Poland
State/province [176] 0 0
Krakow
Country [177] 0 0
Poland
State/province [177] 0 0
Lublin
Country [178] 0 0
Poland
State/province [178] 0 0
Plock
Country [179] 0 0
Poland
State/province [179] 0 0
Torun
Country [180] 0 0
Poland
State/province [180] 0 0
Warsaw
Country [181] 0 0
Poland
State/province [181] 0 0
Wloszczowa
Country [182] 0 0
Romania
State/province [182] 0 0
Brasov
Country [183] 0 0
Romania
State/province [183] 0 0
Cluj-Napoca
Country [184] 0 0
Romania
State/province [184] 0 0
Iasi
Country [185] 0 0
Romania
State/province [185] 0 0
Ploiesti
Country [186] 0 0
Russian Federation
State/province [186] 0 0
Barnaul
Country [187] 0 0
Russian Federation
State/province [187] 0 0
Kazan
Country [188] 0 0
Russian Federation
State/province [188] 0 0
Kemerovo
Country [189] 0 0
Russian Federation
State/province [189] 0 0
Khanty-Mansiysk
Country [190] 0 0
Russian Federation
State/province [190] 0 0
Kursk
Country [191] 0 0
Russian Federation
State/province [191] 0 0
Moscow
Country [192] 0 0
Russian Federation
State/province [192] 0 0
Nizhny Novgorod
Country [193] 0 0
Russian Federation
State/province [193] 0 0
Novosibirsk
Country [194] 0 0
Russian Federation
State/province [194] 0 0
Petrozavodsk
Country [195] 0 0
Russian Federation
State/province [195] 0 0
Ryazan
Country [196] 0 0
Russian Federation
State/province [196] 0 0
Saint Petersburg
Country [197] 0 0
Russian Federation
State/province [197] 0 0
Saratov
Country [198] 0 0
Russian Federation
State/province [198] 0 0
Stavropol
Country [199] 0 0
Russian Federation
State/province [199] 0 0
Voronezh
Country [200] 0 0
Russian Federation
State/province [200] 0 0
Yaroslavl
Country [201] 0 0
Slovakia
State/province [201] 0 0
Bratislava
Country [202] 0 0
Slovakia
State/province [202] 0 0
Dunajska Streda
Country [203] 0 0
Slovakia
State/province [203] 0 0
Piestany
Country [204] 0 0
South Africa
State/province [204] 0 0
Benoni
Country [205] 0 0
South Africa
State/province [205] 0 0
Bloemfontein
Country [206] 0 0
South Africa
State/province [206] 0 0
Breyten
Country [207] 0 0
South Africa
State/province [207] 0 0
Cape Town
Country [208] 0 0
South Africa
State/province [208] 0 0
Durban
Country [209] 0 0
South Africa
State/province [209] 0 0
Limpopo
Country [210] 0 0
South Africa
State/province [210] 0 0
Pretoria
Country [211] 0 0
South Africa
State/province [211] 0 0
Somerset West
Country [212] 0 0
South Africa
State/province [212] 0 0
Stellenbosch
Country [213] 0 0
Spain
State/province [213] 0 0
Barcelona
Country [214] 0 0
Spain
State/province [214] 0 0
Bilboa
Country [215] 0 0
Spain
State/province [215] 0 0
La Coruña
Country [216] 0 0
Spain
State/province [216] 0 0
Madrid
Country [217] 0 0
Spain
State/province [217] 0 0
San Sebastian
Country [218] 0 0
Sri Lanka
State/province [218] 0 0
Colombo
Country [219] 0 0
Sri Lanka
State/province [219] 0 0
Galle
Country [220] 0 0
Sri Lanka
State/province [220] 0 0
Kalubowila
Country [221] 0 0
Sri Lanka
State/province [221] 0 0
Nugegoda
Country [222] 0 0
Taiwan
State/province [222] 0 0
Keelung
Country [223] 0 0
Taiwan
State/province [223] 0 0
Kuei Shan Hsiang
Country [224] 0 0
Taiwan
State/province [224] 0 0
Niao Sung Hsiang
Country [225] 0 0
Taiwan
State/province [225] 0 0
Taichung
Country [226] 0 0
Taiwan
State/province [226] 0 0
Taipei
Country [227] 0 0
Ukraine
State/province [227] 0 0
Dnipropetrovsk
Country [228] 0 0
Ukraine
State/province [228] 0 0
Donetsk
Country [229] 0 0
Ukraine
State/province [229] 0 0
Kharkiv
Country [230] 0 0
Ukraine
State/province [230] 0 0
Kiev
Country [231] 0 0
Ukraine
State/province [231] 0 0
Kyiv
Country [232] 0 0
Ukraine
State/province [232] 0 0
Odesa
Country [233] 0 0
Ukraine
State/province [233] 0 0
Poltava
Country [234] 0 0
Ukraine
State/province [234] 0 0
Simferopol
Country [235] 0 0
Ukraine
State/province [235] 0 0
Vinnitsa
Country [236] 0 0
Ukraine
State/province [236] 0 0
Vinnytsya

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Eli Lilly and Company
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The primary purpose of this study is to help answer if LY2127399 is safe and effective during long-term treatment in participants with Rheumatoid Arthritis.

This study is comprised of 2 periods:

Period 1: Unblinded treatment for up to 240 weeks for participants who enroll from Study H9B-MC-BCDO (BCDO) (NCT01202760) or Study H9B-MC-BCDV (BCDV) (NCT01202773) or up to 168 weeks for participants who enroll from Study H9B-MC-BCDM (BCDM) (NCT01198002).

Period 2: 48-week post-treatment follow-up
Trial website
https://clinicaltrials.gov/study/NCT01215942
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Call 1-877-CTLILLY(1-877-285-4559) or 1-317-615-4559 Mon - Fri 9AM - 5PM Eastern time (UCT/GMT - 5 hours, EST)
Address 0 0
Eli Lilly and Company
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT01215942